Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host epithelial and immune cells refers to the integrated cellular network comprising the body's physical barriers and its primary defense mechanisms. Epithelial cells provide a structural and chemical shield against pathogens, while immune cells, including lymphocytes and myeloid cells, coordinate the inflammatory response (NIH, 2023). The crosstalk between these populations, often termed the epithelial-immune axis, is essential for maintaining tissue homeostasis and responding to environmental stimuli (PubMed, 2022). Dysregulation of this interaction is a hallmark of various inflammatory and autoimmune conditions, such as asthma and inflammatory bowel disease (StatPearls, 2024). Because this term encompasses a vast array of distinct cell types and molecular pathways, it does not constitute a single, druggable therapeutic target. Pharmacological intervention typically focuses on specific receptors or enzymes within these cells rather than the entire population (UniProt, 2024).
Not applicable as this refers to a broad cellular population rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host epithelial and immune cells.